Ischemia-modified albumin as an oxidative stress biomarker in obesity

Clinical Biochemistry

Volumn 44, Issue 4, 2011, Pages 345-347

  Piva, Sílvia J ^a   Duarte, Marta M M F ^b   Da Cruz, Ivana B M ^a   Coelho, Adriane C ^c   Moreira, Ana Paula L ^a   Tonello, Raquel ^a   Garcia, Solange C ^a,d   Moresco, Rafael N ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

^c Hospital Universitario de Santa Maria   (Brazil)

^d FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Human serum albumin; Obesity; Oxidative stress

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISCHEMIA MODIFIED ALBUMIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; TRIACYLGLYCEROL;

ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE MARKER; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL;

BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL, HDL; CHOLESTEROL, LDL; HUMANS; ISCHEMIA; MALE; MALONDIALDEHYDE; MIDDLE AGED; OBESITY; OXIDATIVE STRESS; SERUM ALBUMIN; TRIGLYCERIDES;

EID: 79651471376     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2010.12.001     Document Type: Article

References (11)

1. Malnick S.D.H., Knobler H. The medical complications of obesity. QJM 2006, 99:565-579.
2. Flegal K.M., Carroll M.D., Ogden C.L., Curtin L.R. Prevalence and trends in obesity among US Adults, 1999-2008. JAMA 2010, 303:235-241.
3. Grundy S.M., Brewer H.B., Cleeman J.I., Smith S.C., Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004, 109:433-438.
4. Vincent H.K., Taylor A.G. Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int J Obes 2006, 30:400-418.
5. Bourdon E., Loreau N., Blache D. Glucose and free radicals impair the antioxidant properties of serum albumin. FASEB J 1999, 13:233-244.
6. Duarte M.M.M.F., Rocha J.B., Moresco R.N., Duarte T., Da Cruz I.B., Loro V.L., Schetinger M.R. Association between ischemia-modified albumin, lipids and inflammation biomarkers in patients with hypercholesterolemia. Clin Biochem 2009, 42:666-671.
7. Kaefer M., Piva S.J., De Carvalho J.A., Da Silva D.B., Becker A.M., Coelho A.C., et al. Association between ischemia modified albumin, inflammation and hyperglycemia in type 2 diabetes mellitus. Clin Biochem 2010, 43:450-454.
8. Gottlieb M.G.V., Da Cruz I.B.M., Duarte M.M.F., Moresco R.N., Wiehe M., Schwanke C.H.A., et al. Associations among metabolic syndrome, ischemia, inflammatory, oxidatives, and lipids biomarkers. J Clin Endocrinol Metab 2010, 95:586-591.
9. Bhagavan N.V., Ha J.S., Park J.H., Honda S.A., Rios C.N., Sugiyama C., et al. Utility of serum fatty acid concentrations as a marker for acute myocardial infarction and their potential role in the formation of ischemia-modified albumin: a pilot study. Clin Chem 2009, 55:1588-1590.
10. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of lowdensity lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
11. Grotto D., Santa Maria L.D., Boeira S., Valentini J., Charão M.F., Moro A.M., et al. Rapid quantification of malondialdehyde in plasma by high performance liquid chromatography-visible detection. J Pharm Biomed Anal 2007, 43:619-624.